Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limited versus full sternotomy for aortic valve replacement.

Bilal H Kirmani1, Sion G Jones1, S C Malaisrie2

  • 1Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, Merseyside, UK, L14 3PE.

The Cochrane Database of Systematic Reviews
|April 11, 2017
PubMed
Summary

Minimally invasive aortic valve replacement (AVR) via limited sternotomy shows potential benefits like reduced blood loss and shorter ICU stays. However, evidence quality is low to moderate, necessitating further research for definitive conclusions on safety and efficacy compared to conventional median sternotomy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative Lung Function Assessment and the Impact of Spirometry Misdiagnosis on Mortality Following Cardiac Surgery.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Initial Outcomes from a Minimally Invasive Cardiac Surgery-Off-Pump Coronary Artery Bypass Grafting (MICS-OPCAB) Programme: A Case Series of the First 50 Patients Single-Centre Experience.

Journal of cardiovascular development and disease·2025
Same author

Left Atrial Appendage Occlusion in Patients Without Atrial Fibrillation Undergoing Cardiac Surgery: The Evidence Is Mounting.

Circulation. Cardiovascular interventions·2024
Same author

Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial.

JAMA·2024
Same author

Antithrombotic therapy after heart valve surgery: contemporary practice in the UK.

Interdisciplinary cardiovascular and thoracic surgery·2024
Same author

Cardioplegia-and science-for global surgery.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2024

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Aortic Valve Replacement

Background:

  • Aortic valve disease is treatable with cardiac surgery, conventionally via median sternotomy.
  • Minimally invasive approaches using limited sternotomy are emerging, raising questions about their safety and efficacy.
  • Concerns exist regarding surgical access, cannulation, and heart management in minimally invasive AVR.

Purpose of the Study:

  • To compare the effects of minimally invasive aortic valve replacement (AVR) via limited sternotomy versus conventional AVR via median sternotomy.
  • To assess patient-relevant outcomes including mortality, operative times, and postoperative complications.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs).

Related Experiment Videos

  • Searches included CENTRAL, MEDLINE, Embase, and clinical trials registries up to July 2016.
  • Excluded trials using other minimally invasive techniques (e.g., mini-thoracotomies, robotic procedures).
  • Main Results:

    • Seven RCTs with 511 participants were included.
    • No significant differences in mortality, cardiopulmonary bypass time, or aortic cross-clamp time were found.
    • Minimally invasive AVR showed lower postoperative blood loss and shorter intensive care unit (ICU) stays, but evidence quality was low to moderate.
    • No significant reduction in deep sternal wound infections, re-exploration, or pain scores was observed.

    Conclusions:

    • Current evidence is of generally low to moderate quality, with small sample sizes limiting definitive conclusions.
    • Uncertainty remains regarding the effects of limited sternotomy AVR on mortality, operative times, and secondary outcomes.
    • A well-designed, adequately powered RCT is needed to establish the efficacy and safety of minimally invasive AVR, including cost-effectiveness and quality-of-life analyses.